Inozyme Pharma's total assets for Q1 2025 were $95.16M, a decrease of -22.75% from the previous quarter. INZY total liabilities were $63.37M for the fiscal quarter, a -3.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.